Want to Know About Pediatric Enuresis? Well, Urine Luck

Want to Know About Pediatric Enuresis? Well, Urine Luck

Guest: Patricio Gargollo, M.D. (@pgargollo)

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

Enuresis is relatively common in children, estimated to be present in as many as 5 to 10% of 7-year-olds. This represents up to 7 million children in the United States. As you can imagine, it carries significant social implications for the child. Our guest for this podcast is Dr. Patricio Gargollo, a pediatric urologist at Mayo Clinic in Rochester, Minnesota. Dr. Gargollo will address the natural history of enuresis, how to evaluate the child with enuresis, how often it represents a structural urologic problem and how often a treatable cause is found. Practical advice for parents of children with enuresis is also discussed.

Specific topics:

  • Potential for children with enuresis to have bladder control problems when they develop into adulthood.
  • Social impact of enuresis on a child.
  • Potential risk factors and causes of enuresis.
  • The role of genetics and enuresis.
  • The natural history of enuresis.
  • How often a structural urologic problem is found to explain enuresis.
  • Pharmacologic treatment options.
  • The evaluation of a child with enuresis.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Episoder(500)

Heart Health Series | Cardiotoxicity of Cancer Therapies

Heart Health Series | Cardiotoxicity of Cancer Therapies

Host: Darryl S. Chutka, M.D.  Guest: Balaji Tamarappoo, M.D., Ph.D.  With advances in oncology, patients are living longer than ever following a diagnosis of cancer. Newer treatments have dramatically...

24 Feb 26min

Heart Health Series | Pericardial Disease

Heart Health Series | Pericardial Disease

Host: Darryl S. Chutka, M.D.  Guest: Hema Narayanasamy, M.B.B.S.  Pericardial disease represents a spectrum of both inflammatory and non-inflammatory disorders which involve the pericardium, with acut...

17 Feb 28min

The Power of Intervals: High Intensity Interval Training and Reducing Cardiovascular Risk

The Power of Intervals: High Intensity Interval Training and Reducing Cardiovascular Risk

Host: Darryl S. Chutka, M.D.  Guest: Stephen Kopecky, M.D.  We have a variety of pharmacologic options and lifestyle changes we recommend to our patients to reduce their cardiovascular risks. One freq...

10 Feb 20min

Heart Health Series | Bicuspid Aortic Valve Disease

Heart Health Series | Bicuspid Aortic Valve Disease

Host: Darryl S. Chutka, M.D.  Guest: George Wang, M.D.  Bicuspid aortic valve is a relatively common congenital heart disease. It can be associated with other genetic disorders such as Turner’s Syndro...

5 Feb 29min

Heart Health Series | Cardiac Amyloidosis

Heart Health Series | Cardiac Amyloidosis

Host: Darryl S. Chutka, M.D.  Guest: Julie Rosenthal, M.D.  Cardiac amyloidosis is not a common condition, but it is important for primary care clinicians to recognize it in our patients. It’s commonl...

3 Feb 29min

Concussions: What Every Primary Care Provider Should Know

Concussions: What Every Primary Care Provider Should Know

Host: Darryl S. Chutka, M.D. Guest: Matthew B. Anastasi, M.D. Patients with concussions are commonly seen in primary care practices and concussions don’t spare any particular age group. Children, youn...

27 Jan 27min

Rx for Weight Loss: A Closer Look Series "The Wins of Losing: GLP-1 Agonists and Reducing Heart Disease Risk"

Rx for Weight Loss: A Closer Look Series "The Wins of Losing: GLP-1 Agonists and Reducing Heart Disease Risk"

Host: Darryl S. Chutka, M.D.  Guest: Stephen Kopecky, M.D.  One of the biggest surprises we’ve seen in medicine in the past several years has been the numerous health benefits realized from the GLP-1 ...

20 Jan 20min

Rx for Weight Loss: A Closer Look Series "Controversies & Future of GLP-1 Medications"

Rx for Weight Loss: A Closer Look Series "Controversies & Future of GLP-1 Medications"

Host: Darryl S. Chutka, M.D.  Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B.  The class of medications known as the GLP-1 agonists is very popular with our patients. Although initially ...

15 Jan 24min

Populært innen Fakta

mikkels-paskenotter
fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
foreldreradet
treningspodden
rss-strid-de-norske-borgerkrigene
jakt-og-fiskepodden
rss-bisarr-historie
hverdagspsyken
sinnsyn
rss-kull
gravid-uke-for-uke
fryktlos
level-up-med-anniken-binz
rss-kunsten-a-leve
tomprat-med-gunnar-tjomlid
hagespiren-podcast
uroskolen
hva-er-greia-med